HCW Biologics Inc. (HCWB) vs PRF Technologies Ltd. (PRFX)

A side-by-side comparison of HCW Biologics Inc. and PRF Technologies Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HCWB vs PRFX

growth of $100 · dividends reinvested · last 5y
HCWB -99.9% (-74.5%/yr)PRFX -99.9% (-74.5%/yr)HCWB compounded faster over this window
050100150Start $10020222023202420252026$0$0
HCWB PRFX

HCWB vs PRFX: by the numbers

  • •HCWB is the larger company ($563178 vs $70876 market cap).
  • •Both run net losses; HCWB's is the smaller (-73.22% vs -22521.52% net margin).

Metrics side by side

Valuation

MetricHCWBPRFX
P/S ratio0.081.79
P/B ratio0.080.00

Profitability

MetricHCWBPRFX
Gross margin20.00%-4864.71%
Operating margin-20757.65%-29335.29%
Net margin-73.22%-22521.52%
ROE-66.26%-56.04%
ROIC-41.92%-53.95%

Growth (annualized)

MetricHCWBPRFX
Revenue CAGR (5Y)-57.90%N/A
Total return CAGR (5Y)-69.71%-74.50%

Frequently asked

How have HCWB and PRFX total returns compared?
Over the past 5 years, HCWB delivered -69.71% and PRFX delivered -74.50% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.